Concepedia

Christopher E. Dahle

CE

Statistics

Publications

12

Citations

1.4K

H-Index

12

Active since

1971

Affiliations

University of Iowa(Current)

University of Iowa Holden Comprehensive Cancer Center

Christopher E. Dahle is an author at University of Iowa specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1971–2011

12

Publications

12

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

George J. Weiner, Hsin-Ming Liu, James E. Wooldridge et al. · Proceedings of the National Academy of Sciences · 1997 · 521 citations · Full text

A Polymorphism in the Complement Component<i>C1qA</i>Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma

Emilian Racila, Brian K. Link, Wen‐Kai Weng et al. · Clinical Cancer Research · 2008 · 150 citations · Full text

Immunostimulatory CpG Oligodeoxynucleotides Enhance the Immune Response to Vaccine Strategies Involving Granulocyte-Macrophage Colony-Stimulating Factor

Hsin-Ming Liu, Sally E. Newbrough, Sudershan K. Bhatia et al. · Blood · 1998 · 123 citations

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism

Suresh Veeramani, Siao‐Yi Wang, Christopher E. Dahle et al. · Blood · 2011 · 119 citations · Full text

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.

Heidi H. van Ojik, Lisette Bevaart, Christopher E. Dahle et al. · PubMed · 2003 · 93 citations

, , +15

1–5 of 12